A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab For Locally Advanced Pancreatic Cancer.

Trial Profile

A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab For Locally Advanced Pancreatic Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Gemcitabine
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2009 Additional lead trial investigator (Fanelle J, Haas A) identified as reported by New Jersey Cancer Trial Connect.
    • 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect, RTOG0411).
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top